Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.
about
Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunctionPolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenChildhood obesity and its impact on the development of adolescent PCOS.The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome.Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controlsCompeting Factors Link to Bone Health in Polycystic Ovary Syndrome: Chronic Low-Grade Inflammation Takes a TollSerum concentrations of afamin are elevated in patients with polycystic ovary syndrome.Gene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index.Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis.Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: a case-control study from syria.Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).The Salivary Microbiome in Polycystic Ovary Syndrome (PCOS) and Its Association with Disease-Related Parameters: A Pilot StudyHbA1c in Patients with Polycystic Ovary Syndrome: A Potential Marker of Inflammation.Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population.Association of TNF-alpha, IL-6 and IL-1beta gene polymorphisms with polycystic ovary syndrome: a meta-analysis.Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinthPolycystic ovary syndrome: current status and future perspectiveThe Higher Response of Vascular Endothelial Growth Factor and Angiotensin-II to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome.Serum tumor necrosis factor-α, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertilityA possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells.Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise.Is PCOS an inflammatory process?Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women.Targets to treat androgen excess in polycystic ovary syndrome.Association of Glomerular Filtration Rate with Inflammation in Polycystic Ovary SyndromeInterleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase.Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome.Medical management of metabolic dysfunction in PCOS.The Role of Serum MicroRNA-6767-5p as a Biomarker for the Diagnosis of Polycystic Ovary SyndromeHigh Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-AnalysisWeight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks.Biomarker Profiles in Women with PCOS and PCOS Offspring; A Pilot Study.Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot StudyThe effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome.Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome.Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary SyndromeGlucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome.Inflammation and Human Ovarian Follicular Dynamics.
P2860
Q27011541-9170BE1F-3F6E-4086-AF72-2C18F8D6A6C3Q27021307-A2ACFE8A-DC49-4EE3-956C-79698C412433Q30405587-12167014-AF80-4B2C-86A1-AB5139974681Q30407754-607B6473-F88F-459B-8F82-361DA33486E7Q33784651-372151ED-73FB-4C77-B0EB-72E290F2CB71Q33794152-AABE5703-7012-4129-B4DC-818C1DADEB42Q33814094-2F76DF24-CB2B-4C27-BE5B-1EA1B8738EB3Q33946386-99E62ED0-CE89-47DD-8858-8605CF94EADEQ34032834-E97E16DB-1D21-4B9D-927E-988627607375Q34196830-771081F8-27CB-4009-8A52-3C0E40F8994EQ34396231-BB2C4494-68DE-4261-A4C4-55FAAD357C87Q34539919-1319FD80-262F-49CB-A95F-D55D9913D44AQ34677026-F3CEC452-7176-48BA-8298-B3EE0CDAD652Q34795100-2CAA3727-AC99-4B50-BAE6-6216BFD2A27BQ35041444-756545E1-262D-4A62-BEF2-72DA5FAEEABFQ35100161-A0B2C5CE-B731-4C85-BBFA-45B9CAEA168DQ35124537-0B5F8944-2BBA-49E0-8D6B-CE981CCC39B0Q35166371-C41FA3EF-BDD5-4FDC-9E81-9028C262E4F6Q35320690-7CA962FA-F66B-4A15-A511-CC0E2F9C674BQ35424614-654BC2B8-6EF3-4B07-951E-6585192F29B8Q35598333-632F4B42-5DCB-47B7-BD7E-5108B3E522D8Q35633277-21C48B21-C28F-4B35-89BD-14F37F143F0AQ35780756-F952C565-4A08-4EC7-9929-17B680139BCAQ35835501-8417D00E-A884-4DA6-90BB-328B96E3588FQ35898943-92C592D2-1EA7-47DF-B671-04A587C3B9A7Q35915837-83EA33CC-7A2E-4F05-8592-D8389B592B84Q35967487-9B72038D-2A3E-4499-A2FF-08A7AE93C9E4Q35994143-935E1128-66D1-4ACB-86A0-2C194F9BDC2DQ36132055-11D31303-4C2C-484D-991D-C8E5CE84357EQ36146144-113D67F3-AFD3-423A-A0FC-464E1B91C498Q36168981-F1D1DC37-822A-4204-A68F-5CB4455F99ADQ36176816-F4D33914-ED81-4183-94DC-96B32D91F8A8Q36180254-D24386AA-52C1-447B-B361-35195D80FFB0Q36237841-6CB9DEA7-CE3D-47D3-8384-FC930E44453EQ36297163-42BC0C98-0D50-4796-83A8-0BAD6A55337BQ36360786-390E401F-5C92-4C2F-8EAB-615A9D148EC1Q36369187-5EC1442C-91CE-4BF6-A98C-DD09992A0013Q36421176-2A1769E5-F989-4FDC-AB14-D5326D31CC99Q36593085-5E5609F3-FD26-4438-8892-3E646FFC2DC7Q36635259-BCC3CD60-0A3E-44CF-8433-2D39D6A650A2
P2860
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Circulating inflammatory marke ...... matic review and metaanalysis.
@ast
Circulating inflammatory marke ...... matic review and metaanalysis.
@en
Circulating inflammatory marke ...... matic review and metaanalysis.
@nl
type
label
Circulating inflammatory marke ...... matic review and metaanalysis.
@ast
Circulating inflammatory marke ...... matic review and metaanalysis.
@en
Circulating inflammatory marke ...... matic review and metaanalysis.
@nl
prefLabel
Circulating inflammatory marke ...... matic review and metaanalysis.
@ast
Circulating inflammatory marke ...... matic review and metaanalysis.
@en
Circulating inflammatory marke ...... matic review and metaanalysis.
@nl
P2860
P31
P921
P1476
Circulating inflammatory marke ...... ematic review and metaanalysis
@en
P2093
Frank González
P2860
P304
1048-58.e1-2
P356
10.1016/J.FERTNSTERT.2010.11.036
P407
P577
2010-12-17T00:00:00Z